| REG-Shire plc: Shire Targets Q4 Filing of BLA for REPLAGAL with US FDA - Reuters |
|
|
ReutersFabry disease affects both males and females and can present with a number of signs or symptoms of variable degree, such as cardiovascular and/or renal ... read more |